EQUIVITA™: OVERVIEW

equivita_edited.jpg

EQUIVITA™ is a device similar to ACESOVITA™ but is calibrated for the size and weight of horses. Immune cells are isolated and treated with TBX-4403. The design of EQUIVITA™ allows the veterinarian to process and administer the treated cells in the field without the need to transport the animal to the veterinary center.

Advantages

Safe

  • Autologous product

  • Prior safety testing

Manufacturing

  • 3-hour process

  • No specialized equipment

Versatile

  • Disease agnostic

  • Capable to perform in field

uma_edited.jpg

Ready for Product Development

Packaging: All-in-one

Distribution: No cold chain

Target Use: Horses

Applications: Solid Tumors, Infectious Disease, Rejuvenation

Market Potential: 9.2 million horses in the U.S

6.2 million horses in Europe

3% of horses are diagnosed with malignancies 

per year.